Erratum: Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes (Journal of Diabetes Science and Technology (2014) 8: 3 (494-497) DOI: 10.1177/1932296814528135);Treatment recommendations following 3-day masked Continuous Glucose Monitoring (CGM) in youth with type 1 diabetes

Journal of Diabetes Science and Technology

Volumn 8, Issue 3, 2014, Pages 494-497

  Rasbach, Lisa E ^a   Atkins, Ashley E ^a   Milaszewski, Kerry M ^a   Keady, Joyce ^a   Schmidt, Lisa M ^a   Volkening, Lisa K ^a   Laffel, Lori M ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

A1c; Continuous glucose monitoring; Pediatrics; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; DISEASE DURATION; EXERCISE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MASKED CONTINUOUS GLUCOSE MONITORING; AGE; BLOOD; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; EATING; METABOLISM; ODDS RATIO; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; BIOMARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; EATING; EXERCISE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900814133     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814539594     Document Type: Erratum

References (12)

1. de Beaufort CE, Swift PG, Skinner CT, et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care. 2007;30:2245-2250. (Pubitemid 47359026)
2. Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36:2035-2037.
3. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29:2730-2732. (Pubitemid 44912209)
4. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-1476.
5. Chase HP, Beck RW, Xing D, et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month followup of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther. 2010;12:507-515.
6. Pepper GM, Steinsapir J, Reynolds K. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice. Diabetes Technol Ther. 2012;14:654-657.
7. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24:1858-1862. (Pubitemid 33716491)
8. Schiaffini R, Ciampalini P, Fierabracci A, et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev. 2002;18:324-329.
9. Swan KL, Weinzimer SA, Dziura JD, et al. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care. 2008;31:44-46.
10. Ryan RL, King BR, Anderson DG, Attia JR, Collins CE, Smart CE. Influence of and optimal insulin therapy for a low-glycemic index meal in children with type 1 diabetes receiving intensive insulin therapy. Diabetes Care. 2008;31:1485-1490.
11. Maahs DM, Mayer-Davis E, Bishop FK, Wang L, Mangan M, McMurray RG. Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept. Diabetes Technol Ther. 2012;14:658-664.
12. Miele A, Weiland K, Dungan KM. Clinical outcomes associated with referral-based continuous glucose monitoring using a central standardized interpretation strategy. Diabetes Technol Ther. 2012;14:765-771.